More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

A new study led by the Medical Research Institute of New Zealand (MRINZ) has found that asthmatic children don't face any additional risk from using inhalers currently reserved for teens and adults.

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

Beclometasone can be administered through various methods, including via an inhaler or 'puffer', which typically comes in ...

Asthma is a widespread respiratory condition affecting approximately 5.4 million people in the UK, and 1.1 million are children. 1,2 Asthma is the most widespread long-term condition among young ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

AIIMS Jodhpur study finds 40% of spacers carry bacteria. Cloth drying increases risk, highlighting a lack of national hygiene guidelines. Experts urge air drying and standardized safety protocols.

Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.

A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.